ReportLinker logo.jpg
United Arab Emirates (UAE) Life Insurance - Key trends and Opportunities to 2023
November 03, 2020 08:45 ET | ReportLinker
New York, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "United Arab Emirates (UAE) Life Insurance - Key trends and Opportunities to 2023" -...
ProgenityLogo.jpg
Progenity to Report Third Quarter 2020 Financial Results and Provide Corporate Update
November 03, 2020 08:43 ET | Progenity, Inc.
SAN DIEGO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
LOGO-PNG.png
Ocuphire Pharma to Host Key Opinion Leader Event on Nyxol® and APX3330
November 03, 2020 08:40 ET | Ocuphire Pharma
FARMINGTON HILLS, Mich., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the...
Staffing360_Logo_Primary.jpg
Staffing 360 Solutions to Host Fiscal Third Quarter and Nine-Month Financial Results Investor Conference Call
November 03, 2020 08:36 ET | Staffing 360 Solutions, Inc.
NEW YORK, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of domestic and...
Abcam plc: Annual Report, Impact Report and Notice of AGM
November 03, 2020 08:35 ET | Abcam
CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on...
OTLK.png
Outlook Therapeutics Completes Patient Enrollment of Open-Label Safety Study for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
November 03, 2020 08:35 ET | Outlook Therapeutics, Inc.
Full enrollment of 195 subjects in NORSE THREE achieved in less than one month, significantly ahead of scheduleAll planned clinical trials for ONS-5010/LYTENAVA™ BLA for wet AMD now fully enrolled or...
Spero.jpg
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2020 08:32 ET | Spero Therapeutics, Inc.
CAMBRIDGE, Mass., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...
ReportLinker logo.jpg
Growth Opportunities in the Hydrogen Market for the Global Power Sector
November 03, 2020 08:32 ET | ReportLinker
New York, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Growth Opportunities in the Hydrogen Market for the Global Power Sector" -...
OSS.png
OSS to Host ‘AI at the Edge’ Webinar Featuring Speaker from NVIDIA
November 03, 2020 08:31 ET | One Stop Systems, Inc.
ESCONDIDO, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (Nasdaq: OSS), a leader in specialized high-performance edge computing, will host its second webinar in a series on how to...
inuvo_logo.png
Inuvo’s IntentKey Enables Political Campaigns to Reach Voters Leading Up to Election Day
November 03, 2020 08:31 ET | Inuvo Inc.
LITTLE ROCK, Ark., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and...